Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details)

v3.21.1
Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details) - shares
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 13,564,707 9,291,165
Stock options    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 6,504,401 5,504,177
Unvested Restricted Stock Units    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 2,070,150 1,641,346
Warrants    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 4,990,156 2,145,642